|
In order to enhance the Company’s corporate governance and reinforce its strategic capabilities, Ilika Technologies Ltd, the science-led materials discovery company, has appointed two independent non-executive directors to its board. This expansion of the board is designed to support the further growth of Ilika’s business.
Dr Werner Braun is the Managing Director of Biotronik, Europe’s largest privately-held bio-medical device company. Dr Braun has played a key role in building Biotronik from an early-stage company to a substantial international business enterprise. Commenting on his appointment, Dr Braun stated, “Ilika has already clearly demonstrated the effectiveness of its technology for rapidly providing materials solutions to some of the most exciting and innovative medical device products. I very much look forward to providing guidance to the Company as it further develops in this rapidly growing sector”.
Dr Karl-Gerhard Seifert was formerly a board member of Hoechst and the CEO of Clariant, the specialty chemicals company. Dr Seifert is currently a member of the advisory board of Deutsche Bank and the Chairman of AllessaChemie. Until December 2006, Dr Seifert was also the Chairman of PEMEAS, the fuel cell company, which was sold to BASF. Regarding his appointment to Ilika’s board, Dr Seifert stated, “Having seen Ilika’s technical expertise applied to energy conversion materials such as fuel cells, hydrogen storage materials and photovoltaics, I am convinced the Company has intellectual property fundamental to the realisation of the low-carbon economy. Its commercial relationships in this area are also very impressive”.
Jack Boyer, Chairman of Ilika, stated, “We are delighted to have attracted two such high calibre individuals to join David Norwood and myself on Ilika’s Board. Dr Braun and Dr Seifert have many years of relevant experience which will help the Company to grow strongly in its chosen markets”. |
